Healthcare press releases — Press Release Database

Healthcare

Si usted es un paciente negro con enfermedad renal registrado en la lista de espera nacional para trasplantes de riñón en un hospital de trasplantes de California o en el Cedars-Sinai Medical Center, desde el año 2000 hasta el presente, podría formar parte de una demanda.

LOS ÁNGELES, 3 de septiembre de 2026 /PRNewswire-HISPANIC PR WIRE/ -- Randall v. United Network for Organ Sharing, et al., caso n.º 2:23-cv-02576-MEMF-MAA, Tribunal de Distrito de los EE. UU. para el Distrito Central de California ¿De qué trata la demanda? Las personas que presentaron la...

Sep 3 · 12:00mlpr-prnewswire-wire

Healthcare

Syra Health, in Partnership with HealthSync, Selected for CMS ACCESS Model, Advancing Long-Term Growth Strategy

CARMEL, Ind., Sept. 3, 2026 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA) ("Syra Health" or the "Company"), an integrated healthcare solutions company powering better health outcomes through prevention-focused, accessible, and affordable solutions, announced today that, in partnership...

Sep 3 · 11:55PR Newswire

Healthcare

Pulnovo Medical Announces Results of the PADN-HF-PH Trial at ESC Congress 2026, Simultaneously Published in The New England Journal of Medicine (NEJM)

Clinical outcomes from 264 PH-LHD patients demonstrate a 51% reduction in the risk of clinical worsening, a 35.5% decrease in recurrent clinical events, and sustained concurrent improvements in functional capacity, supporting the multi-dimensional therapeutic benefits of the Pulmonary...

Sep 3 · 11:53PR Newswire

Healthcare · Retail

Curaleaf Announces September 2026 Conference Participation

STAMFORD, Conn., Sept. 3, 2026 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf"), a leading international provider of consumer and medical cannabis products, today announced that members of Curaleaf's executive management team will be participating in the...

Sep 3 · 11:45PR Newswire

Healthcare

Rhelion Life Sciences Confirms Further Delivery of Filament Health's PEX010 to Germany's First Psilocybin Compassionate Use Program

Filament Health has completed a further international delivery of its patented, naturally derived psilocybin drug candidate PEX010 to Germany, supporting the first compassionate use program for psilocybin in the European UnionThe Company believes the continued delivery demonstrates Filament's ability to manufacture, release and supply pharmaceutical-grade botanical psilocybin across international regulatory jurisdictions as new legal access pathways emergeRhelion intends to leverage Filament's...

Sep 3 · 11:39mlpr-newsfile

Healthcare

Médunik Canada enters into exclusive promotional services agreement with Biocodex for Diacomit® in Canada

Agreement expands support for Canadian healthcare professionals and families impacted by Dravet syndrome BLAINVILLE, QC, Sept. 3, 2026 /PRNewswire/ -- Médunik Canada, a Canadian owned and operated pharmaceutical company dedicated to improving the health and quality of life of people...

Sep 3 · 11:32PR Newswire

Finance · Healthcare

Crescent Biopharma to Present at September Investor Conferences

WALTHAM, Mass., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that management is scheduled to present at the following investor conferences in September:

Sep 3 · 11:30GlobeNewswire

Finance · Healthcare

Eikon Therapeutics Appoints Ching-Pin Chang, M.D., Ph.D. as Executive Vice President and Chief Scientific Officer

MILLBRAE, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Eikon Therapeutics, Inc. (Nasdaq: EIKN) (“Eikon”), a late-stage clinical biopharmaceutical company dedicated to developing innovative medicines to address serious unmet medical needs, today announced the appointment of Ching-Pin (“CP”) Chang, M.D., Ph.D. as Executive Vice President and Chief Scientific Officer.

Sep 3 · 11:30GlobeNewswire

Finance · Healthcare

FDA Grants Fast Track Designation to YUTREPIA® for the Treatment of Raynaud's Phenomenon Associated with Systemic Sclerosis

Liquidia (Nasdaq: LQDA): FDA grants Fast Track designation to YUTREPIA for systemic sclerosis-associated Raynaud's phenomenon; Phase 2a study in Q4 2026

Sep 3 · 11:30GlobeNewswire

Finance · Healthcare

Helus Pharma to Participate at the 2026 Cantor Global Healthcare Conference in New York

CEO Michael Halstead to participate in a fireside chat on Friday, September 11, 2026 at 8:00 a.m. EDT. CEO Michael Halstead to participate in a fireside chat on Friday, September 11, 2026 at 8:00 a.m. EDT.

Sep 3 · 11:30GlobeNewswire

Healthcare

Perspecta Releases New Industry Research on Provider Data Quality & Directory Inaccuracies Across U.S. Health Plans

Report analyzes 12 months of provider directory audits and millions of provider records to identify systemic data quality challenges and outline a roadmap for operational improvement. LANGHORNE, Pa., Sept. 3, 2026 /PRNewswire/ -- Perspecta today announced the release of The State of...

Sep 3 · 11:30PR Newswire

Finance · Healthcare

Trevi Therapeutics to Participate in Upcoming September Conferences

NEW HAVEN, Conn., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF), non-IPF interstitial lung disease (non-IPF ILD), and refractory chronic cough (RCC), today announced that senior management will participate in the following conferences in September.

Sep 3 · 11:30GlobeNewswire